自引率: 6.7%
被引量: 4236
通过率: 暂无数据
审稿周期: 1.78
版面费用: 暂无数据
国人发稿量: 暂无数据
投稿须知/期刊简介:
Microbial Biotechnology publishes papers of original research reporting significant advances in any aspect of microbial applications, including, but not limited to biotechnologies related to:Green chemistryPrimary metabolitesFood, beverages and supplementsSecondary metabolites and natural productsPharmaceuticalsDiagnosticsAgricultureBioenergyBiomining, including oil recovery and processingBioremediationBiopolymers, biomaterialsBionanotechnologyBiosurfactants and bioemulsifiersCompatible solutes and bioprotectantsBiosensors, monitoring systems, quantitative microbial risk assessmentTechnology developmentProtein engineeringFunctional genomicsMetabolic engineeringMetabolic designSystems analysis, modellingProcess engineeringBiologically-based analytical methodsMicrobially-based strategies in public healthMicrobially-based strategies to influence global processesIt will be a sister of the premier microbiology journals Molecular Microbiology, Environmental Microbiology andCellular Microbiology.The types of articles to be published are:Research ArticlesBrief ReportsRapid CommunicationsReviewsMinireviewsGenomics UpdateNetwatchEditorialsCorrespondenceIn addition, other items relating to the journal content and biotechnological applicability will be regularly featured.Special IssuesEach year, one or two issues will be Special Issues devoted to particularly topical subjects, and edited by expert guest editors.<br clear="none" style="font-family: Arial, " lucida="" grande",="" geneva,="" verdana,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">Keywords<br clear="none" style="font-family: Arial, " lucida="" grande",="" geneva,="" verdana,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">Microbial Biotechnology, Biotechnology, Green chemistry, Primary metabolites, Food, beverages and supplements, Secondary metabolites and natural products, Pharmaceuticals, Diagnostics, Agriculture, Bioenergy , biomining, including oil recovery and processing, Bioremediation, Biopolymers, biomaterials, Bionanotechnology, Biosurfactants and bioemulsifiers, Compatible solutes and bioprotectants, Biosensors, monitoring systems, quantitative microbial risk assessment, Technology development, Protein engineering, Functional genomics, Metabolic engineering, Metabolic design, Systems analysis, modelling, Process engineering, Biologically-based analytical methods <br clear="none" style="font-family: Arial, " lucida="" grande",="" geneva,="" verdana,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">Abstracting and Indexing Information<br clear="none" style="font-family: Arial, " lucida="" grande",="" geneva,="" verdana,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" user-select:="" text="" !important;"="">Abstracts on Hygiene & Communicable Diseases (CABI)AgBiotech News & Information (CABI)AgBiotechNet (CABI)Agricultural Engineering Abstracts (CABI)Agroforestry Abstracts (CABI)Biocontrol News & Information (CABI)Biofuels Abstracts (CABI)Biological Abstracts (Clarivate Analytics)BIOSIS Previews (Clarivate Analytics)Biotechnology Citation Index (Clarivate Analytics)CAB Abstracts® (CABI)CABDirect (CABI)CAS: Chemical Abstracts Service (ACS)Crop Physiology Abstracts (CABI)Dairy Science Abstracts (CABI)Field Crop Abstracts (CABI)Forest Products Abstracts (CABI)Forestry Abstracts (CABI)Global Health (CABI)Horticultural Science Abstracts (CABI)Index Veterinarius (CABI)Irrigation & Drainage Abstracts (CABI)Maize Abstracts (CABI)MEDLINE/PubMed (NLM)Nutrition Abstracts & Reviews Series A: Human & Experimental (CABI)Nutrition Abstracts & Reviews Series B: Livestock Feeds & Feeding (CABI)Ornamental Horticulture (CABI)Plant Breeding Abstracts (CABI)Plant Genetic Resources Abstracts (CABI)Review of Agricultural Entomology (CABI)Review of Plant Pathology (CABI)Rice Abstracts (CABI)Science Citation Index Expanded (Clarivate Analytics)Seed Abstracts (CABI)Soils & Fertilizers Abstracts (CABI)Sugar Industry Abstracts (CABI)Tropical Diseases Bulletin (CABI)Veterinary Bulletin (CABI)Web of Science (Clarivate Analytics)Weed Abstracts (CABI)Wheat, Barley & Triticale Abstracts (CABI)
期刊描述简介:
Microbial Biotechnology publishes papers of original research reporting significant advances in any aspect of microbial applications, including, but not limited to biotechnologies related to: Green chemistry Primary metabolites Food, beverages and supplements Secondary metabolites and natural products Pharmaceuticals Diagnostics Agriculture Bioenergy Biomining, including oil recovery and processing Bioremediation Biopolymers, biomaterials Bionanotechnology Biosurfactants and bioemulsifiers Compatible solutes and bioprotectants Biosensors, monitoring systems, quantitative microbial risk assessment Technology development Protein engineering Functional genomics Metabolic engineering Metabolic design Systems analysis, modelling Process engineering Biologically-based analytical methods Microbially-based strategies in public health Microbially-based strategies to influence global processes It will be a sister of the premier microbiology journals Molecular Microbiology, Environmental Microbiology and Cellular Microbiology.
-
The Arrival of Highly Pathogenic Avian Influenza Viruses in North America, Ensuing Epizootics in Poultry and Dairy Farms and Difficulties in Scientific Naming.
The highly pathogenic avian influenza virus (HPAIV) H5N1, first isolated in 1996 in China, spread rapidly across Eurasia and caused major epizootics in wild and domesticated birds, as well as spillover infections in humans characterised by high mortality. Avian influenza viruses are therefore candidate viruses for a human pandemic. Surprisingly, HPAIV was not isolated in North America until 2014. With the help of intensive biological sampling and viral genome sequencing, the intrusion of HPAIV into North America could be retraced to two separate events. First, migratory birds carried HPAIV from East Siberia via Beringia and dispersed the virus along the Pacific flyway. After reassortment with genes of local low pathogenic avian influenza viruses, HPAIV H5 caused 2015 a major epizootic on poultry farms in the US Mid-West. After costly containment, HPAIV dropped below the detection limit. In 2021, Eurasian HPAIV H5 viruses arrived a second time in North America, carried by migratory birds to Canada via the Atlantic flyway, using Iceland as a stop. The H5 virus then spread with water birds along the East Coast of the United States and dispersed across the United States. In contrast to the 2015 poultry outbreak, spillover infections into diverse species of mammals were now observed. The events culminated in the 2024 HPAIV H5 epizootic in dairy cows affecting 300 dairy herds in 14 US states. The cattle epizootic was spread mainly by milking machinery and animal transport. On affected farms infected cats developed fatal neurological diseases. Retail milk across the United States frequently contains viral RNA, but so far only a few milk farm workers have developed mild symptoms. The tracing of HPAIV with viral genome sequencing complicated the taxonomical naming of influenza viruses raising fundamental problems in how to mirror biological complexity in written plain language, rendering communication with the lay public difficult.
被引量：- 发表：2024
-
Biodegradation of DDT using multi-species mixtures: From genome-mining prediction to practical assessment.
被引量：- 发表：2024
-
Degradation of polyethylene terephthalate (PET) plastics by wastewater bacteria engineered via conjugation.
被引量：- 发表：2024
-
Entrapment of antimicrobial compounds in a metal matrix for crop protection.
被引量：- 发表：2024
-
Bacterioruberin extract from Haloarchaea Haloferax marinum: Component identification, antioxidant activity and anti-atrophy effect in LPS-treated C2C12 myotubes.
Carotenoids are natural pigments utilized as colourants and antioxidants across food, pharmaceutical and cosmetic industries. They exist in carbon chain lengths of C30, C40, C45 and C50, with C40 variants being the most common. Bacterioruberin (BR) and its derivatives are part of the less common C50 carotenoid group, synthesized primarily by halophilic archaea. This study analysed the compositional characteristics of BR extract (BRE) isolated from 'Haloferax marinum' MBLA0078, a halophilic archaeon isolated from seawater near Yeoungheungdo Island in the Republic of Korea, and investigated its antioxidant activity and protective effect on lipopolysaccharide (LPS)-induced C2C12 myotube atrophy. The main components of BRE included all-trans-BR, monoanhydrobacterioruberin, 2-isopentenyl-3,4-dehydrorhodopin and all-trans-bisanhydrobacterioruberin. BRE exhibited higher antioxidant activity and DNA nicking protection activity than other well-known C40 carotenoids, such as β-carotene, lycopene and astaxanthin. In C2C12 myotubes, LPS treatment led to a reduction in myotube diameter and number, as well as the hypertranscription of the muscle-specific ubiquitin ligase MAFbx and MuRF1. BRE mitigated these changes by activating the Akt/mTOR pathway. Furthermore, BRE abolished the elevated cellular reactive oxygen species levels and the inflammation response induced by LPS. This study demonstrated that 'Hfx. marinum' is an excellent source of natural microbial C50 carotenoids with strong antioxidant capacity and may offer potential protective effects against muscle atrophy.
被引量：- 发表：2024
